Fortitude Family Office’s Century Therapeutics IPSC Stock Holding History

Fortitude Family Office’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$720	Hold	294	–	–	﹤0.01%	1872
2026 Q1	$664	Buy	+294	New	+$618	﹤0.01%	1625

Other funds holding IPSC

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Fortitude Family Office's IPSC Position: Q2 2026 in Review

Fortitude Family Office held its Century Therapeutics (IPSC) position steady in Q2 2026 at 294 shares worth $720. The position accounts for ﹤0.01% of the portfolio, ranked #1872.

Fortitude Family Office first reported a position in IPSC in Q1 2026 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

Fortitude Family Office held 294 shares of Century Therapeutics worth $720 as of Q2 2026.
Fortitude Family Office left its Century Therapeutics share count unchanged in Q2 2026.
Century Therapeutics made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1872 holding.
Fortitude Family Office first reported a position in Century Therapeutics in Q1 2026 and has held it in 2 quarters since.
6 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.